Coronavirus vaccine shot being administered. (Representative image) Credit: Yoichi Hayashi/AP/AAP
The US Food and Drug Administration (FDA) is set to revise its approval process for COVID-19 vaccines, potentially limiting future boosters to older adults and those at higher risk of severe illness. The move has sparked questions about how this change could influence Australia’s vaccine strategy and access to boosters in the future.
The US Food and Drug Administration (FDA) is set to revise its approval process for COVID-19 vaccines, potentially limiting future boosters to older adults and those at higher risk of severe illness. The move has sparked questions about how this change could influence Australia’s vaccine strategy and access to boosters in the future.
